Maintain TXN at lower end of benchmark weight through Q3 2026 earnings with $265 target and disciplined $238-242 stop
Three analysts converge on HOLD as the directional call, supported by an unambiguous empirical record: five consecutive prior Hold calls on TXN (9/22-9/29) systematically outperformed Underweight trims (9/18 at +0.0% alpha, 9/21 at +0.2% alpha) because trim-execution drag burns alpha when the bearish thesis rests on technical resistance rather than deteriorating fundamentals. No confirmed fundamental break exists: revenue grew five consecutive quarters ($4.42B → $5.46B), GM at 61.4% (third consecutive expansion), EPS nearly doubled off trough, FCF inflected ~4x YoY to $2.19B, and 200 SMA at $246 continues rising. Maintain lower end of benchmark weight through Q3 earnings with corrected $238-242 stop (replacing invalid $263 stop above entry), add-zone time-stop per 9/29 lesson, and explicit Q3 print triggers defining upgrade to Overweight at $265-275 or Underweight with 15-20% trim on weakness.
| Position | Action |
|---|---|
| Default positioning | Lower end of benchmark weight |
| Valid scale-in entry at $260 with $238-242 stop structure | Full position size with stop below lowest scale-in tranche ($246) |
| Breakout above $283.83 with successful SMA retest | Re-entry at $266-274 zone |
TXN is a best-in-class industrial compounder with operating leverage from 300mm fabs, manufacturing cost advantages, and a fortress balance sheet trading at 26.3x forward P/E with a PEG of 1.0, with margins, cash flow, and technical momentum all coiling for upside.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $274.15 | bullish |
| 50 SMA | $270.42 | bullish |
| 200 SMA | $246.05 | bullish |
| RSI (14) | 60.91 | bullish |
| MACD | +2.87 | bullish |
| MACD Signal | +0.33 | bullish |
| MACD Histogram | +2.54 | bullish |
| Bollinger Upper | $283.83 | neutral |
| Bollinger Middle | $266.56 | bullish |
| Bollinger Lower | $249.28 | neutral |
| ATR (14) | 7.71 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Soft industrial/auto commentary OR GM compression below 57% OR guidance disappointment
Then: Re-evaluate toward Underweight with 15-20% trim regardless of price
Trailing P/E is misleading; forward multiple is reasonable relative to accelerating earnings growth
EV: +15-18% · concedes: TXN is not a hyper-growth AI pure play; 30Y Treasury at highest level since 2002 with mortgages at 7.58%; Polymarket odds for no Fed rate cuts in 2026 at 97%
TXN is a classic late-cycle quality trap: the "inflection" story is built on trough comparisons and optimistic sell-side estimates, the stock has already re-rated significantly (up 89.6% over 3 years, 56% YTD), and the 42.5x trailing P/E leaves no room for execution disappointment in a macro environment with 30Y yields at post-2002 highs actively compressing equity multiples.
EV: -12% pullback to $246 (200 SMA) more likely than breakout to $321 in next 60 days · concedes: TXN's earnings are arguably more durable than NVDA's (the bear grants half this point); Dividend coverage at 2.7x FCF is technically 'comfortable'; The 23-year dividend growth streak is an impressive achievement; Capex has legitimately inflected from $1.31B peak
→ vs conservative: Bear case anchoring to 42.5x trailing P/E ignores that forward P/E is 26.3x; denominator is wrong and earnings trajectory has inflected
→ vs conservative: NVDA comparison is intellectually lazy; TXN is a mature compounder with 2.16% yield and 7% dividend growth, not an AI optionality play
→ vs conservative: Suspended buybacks are funding the 300mm fab ramp, which is correct capital allocation; buyback drought is the setup, not a concern
→ vs neutral: 'Failed close at upper Bollinger Band' misreads the tape; MACD cross, histogram expansion, and moving average stack confirm bullish structure
→ vs neutral: Overweighting 30-year at 2002 highs while underweighting 8% recession odds and tariff de-escalation signals
→ vs neutral: Scaling in tranches at 260, 250, and below 246 is paralysis not prudence; MACD cross and momentum alignment suggest buying strength, not just weakness
Support: 274.15 · 270.42 · 266.56 · 249.28 · 246.05 | Resistance: 283.83 · 295 · 297 · 321 · 332
TXN exhibits a bullish technical setup with price above all three major moving averages (10 EMA $274.15, 50 SMA $270.42, 200 SMA $246.05) in a textbook bullish stack alignment. The MACD bullish crossover occurred on 2026-09-08 with histogram expanding for 14 consecutive sessions, while RSI at 60.91 sits comfortably below overbought territory with room to run. Bollinger Bands show price approaching upper resistance at $283.83, with ATR compressed at 7.71 (down from ~$12.6 in early August), indicating a coiled volatility setup that could trigger directional expansion. Support levels are identified at $274.15 (10 EMA), $270.42 (50 SMA), and $266.56 (Bollinger middle), while resistance sits at $283.83 (upper BB) and $295-297 (early September supply zone).
Market Cap
$255.79B
P/E (TTM)
42.50x
Forward P/E
26.31x
PEG Ratio
1.0
Price/Book
14.20x
EPS (TTM)
$6.59
Forward EPS
$10.64
Dividend Yield
2.16%
Beta
1.314
52-Week High
$334.03
52-Week Low
$152.73
50-Day Avg
$270.85
200-Day Avg
$247.23
TTM Revenue
$19.45B
Gross Profit
$11.35B
Gross Margin
~58.3%
EBITDA
$9.52B
Operating Margin
42.58%
Profit Margin
31.11%
Return on Equity (ROE)
35.18%
Return on Assets (ROA)
13.06%
Q2 2026 Revenue
$5,463M
Q2 2026 Gross Profit
$3,352M
Q2 2026 Operating Income
$2,327M
Q2 2026 Net Income
$1,980M
Q2 2026 Diluted EPS
$2.14
Q2 2026 Gross Margin
61.4%
Q2 2026 Operating Margin
42.6%
Q2 2026 Net Margin
36.2%
Q1 2026 Revenue
$4,825M
Q1 2026 Diluted EPS
$1.68
Q4 2025 Revenue
$4,423M
Q4 2025 Diluted EPS
$1.27
Q3 2025 Revenue
$4,742M
Q3 2025 Diluted EPS
$1.48
Q2 2025 Revenue
$4,448M
Q2 2025 Diluted EPS
$1.41
Q2 2026 Cash & ST Investments
$7.00B
Q2 2026 Inventory
$4.61B
Q2 2026 Receivables
$2.52B
Q2 2026 Total Current Assets
$15.76B
Q2 2026 Net PPE
$11.91B
Q2 2026 Goodwill & Intangibles
$4.64B
Q2 2026 Total Assets
$35.88B
Q2 2026 Long-Term Debt
$12.90B
Q2 2026 Current Debt
$1.15B
Q2 2026 Total Debt
$14.05B
Q2 2026 Stockholders' Equity
$18.01B
Q2 2026 Net Debt
$10.39B
Current Ratio
4.86x
Debt/Equity
78.0%
Q2 2026 Operating Cash Flow
$2.70B
Q2 2026 CapEx
-$514M
Q2 2026 Free Cash Flow
$2.19B
Q2 2026 Dividends Paid
-$1.30B
Q2 2026 Net Buybacks/Issuance
+$418M
TTM Free Cash Flow
$3.55B
Quarterly Dividend
~$1.29B
Treasury Stock (Q2 2026)
$41.94B
Retained Earnings (Q2 2026)
$53.16B
CapEx Peak (Q2 2025)
$1.31B
Cumulative CapEx (5 quarters)
exceeds $4.6B
R&D (Q2 2026)
~$535M
SG&A (Q2 2026)
~$490M
Gross PPE (Q2 2025)
$16.88B
Gross PPE (Q2 2026)
$17.86B
Accumulated Depreciation (Q2 2025)
$4.56B
Accumulated Depreciation (Q2 2026)
$5.95B
Implied Current Price
~$280.13
Strengths
Concerns
HOLD
Macro: Higher-for-longer rate regime dominates with 30-year Treasury at highest since 2002 and mortgage rates at 7.58%; September posted monthly losses for Dow and S&P 500 amid yield climb though Friday Sept 25 achieved weekly gains; cooler-than-expected September inflation print provided one-day relief rally; US-China diplomatic engagement at leader level suggests easing tech/semiconductor risk premium; sector capex remains robust with AMAT posting record $7B chipmaking tool sales.